Gain Therapeutics will be attending JP Morgan HealthCare Conference Jan 8th to 11th, 2024 in San Francisco.
Representing will be:
CEO Matthias Alder
CFO Evan Ballantyne
SVP of Research Joanne Taylor
Director of Business Development Roshan Ahmed
To connect prior to or during the event, please contact Evan Ballantyne at firstname.lastname@example.org
Mon, 8 Jan 2024, 09:00 through Thu, 11 Jan 2024, 18:00
Howard Street 747
San Francisco, 94103
For more information about the actual conference see: https://www.jpmorgan.com/about-us/events-conferences/health-care-conference
The annual J.P. Morgan Healthcare Conference, a behemoth gathering of the healthcare world, boasts a surprisingly humble origin story. It wasn’t always the star-studded, deal-making frenzy we know today. To truly appreciate its evolution, we need to peel back the layers of time and delve into its fascinating history.
In 1983, a pioneering investment bank named Hambrecht & Quist (H&Q) saw the burgeoning potential of the biotechnology industry. To foster connections and catalyze growth, they planted the seed of the Healthcare Conference in San Francisco’s iconic Westin St. Francis Hotel. It was an intimate affair, with just 20 companies showcasing their innovations to a mere 200 attendees. The focus was laser-sharp: biotech, the industry H&Q championed.
As the years rolled by, the conference mirrored the dynamic growth of healthcare itself. The guest list swelled, mirroring the influx of investors drawn to the industry’s promise. H&Q’s visionary gamble paid off, and the conference became a must-attend event for those keen on navigating the ever-evolving landscape.
Then came the turn of the millennium. In 2000, Chase Manhattan Corporation, recognizing the conference’s clout, acquired H&Q. A year later, J.P. Morgan acquired Chase, bringing the Healthcare Conference under its formidable umbrella. This marked a pivotal moment.
With J.P. Morgan’s global reach and financial muscle, the conference metamorphosed. The guest list exploded, attracting thousands of investors from every corner of the globe. The company roster blossomed, welcoming not just fledgling biotechs but established giants with market caps exceeding $300 billion. The scope broadened, encompassing the entire healthcare spectrum – from pharmaceutical giants to nimble startups to profit-driven corporations to the noble pursuits of non-profits.
Today, the J.P. Morgan Healthcare Conference is more than just a gathering. It’s a crucible where deals are forged, trends are dissected, and the future of healthcare is envisioned. The whispers echoing through the Westin St. Francis corridors hold the power to revolutionize treatments, reshape policies, and ultimately impact millions of lives.
We at Gain Therapeutics are excited to attend and share our story in the spirit of innovation that has been nurtured in the remarkable journey of this conference.